This site is intended for healthcare professionals
Drug information

Clarithromycin 500 mg powder for concentrate for solution for infusion

POM
Read time: 29 mins
Last updated: 08 Sep 2020
Published: 08 Sep 2020

4.1 Therapeutic indications

Clarithromycin is indicated in adults and children 12 years and older.

Clarithromycin is indicated when parenteral therapy is required for treatment of infections caused by susceptible organisms in the following conditions (see sections 4.4 and 5.1);

- Acute exacerbation of chronic bronchitis

- Community acquired pneumonia

- Acute bacterial sinusitis (adequately diagnosed)

- Streptococcal pharyngitis and tonsillitis

- Skin and soft tissue infections

Consideration should be given to official guidance on the appropriate use of antibacterial agents.

Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

 

 

Disclaimer

The drug SPC information (indications, contra-indications, interactions, etc), has been developed in collaboration with eMC (www.medicines.org.uk/emc/). Medthority offers the whole library of SPC documents from eMC.

Medthority will not be held liable for explicit or implicit errors, or missing data.

Reporting of suspected adverse reactions 

Drug Licencing

Drugs appearing in this section are approved by UK Medicines & Healthcare Products Regulatory Agency (MHRA), & the European Medicines Agency (EMA).